Kumaravel Somasundaram

Last updated

Kumaravel Somasundaram
Born (1962-10-08) 8 October 1962 (age 61)
Tamil Nadu, India
Nationality Indian
Alma mater
Known forStudies on Glioblastoma
Awards
Scientific career
Fields
Institutions
Doctoral advisor

Kumaravel Somasundaram (born 8 October 1962) is an Indian cancer biologist and a professor at the Department of Microbiology and Cell Biology of the Indian Institute of Science. Known for his studies on the therapeutics of Glioblastoma, Somasunderam is an elected fellow of all the three major Indian science academies namely, the National Academy of Sciences, India, the Indian Academy of Sciences and the Indian National Science Academy. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2006.

Contents

Biography

Madurai Kamaraj University-front view Madhurai kamaraj university front view.JPG
Madurai Kamaraj University-front view

Kumaravel Somasundaram, born on 8 October 1962 [1] in the south Indian state of Tamil Nadu, graduated in veterinary medicine from the Madras Veterinary College and did his post-graduate studies at the Madurai Kamaraj University to earn an MSc in biotechnology. [2] He continued at the university for his doctoral studies under the guidance of Kuppamuthu Dharmalingam and after securing a PhD, he moved to the US for his post-doctoral work which he did, first under Bayar Thimmapaya at the Northwestern University Medical School during 1993–95 and later, at the Howard Hughes Medical Institute of the University of Pennsylvania, working on DNA tumor viruses and tumor suppressor genes , supervised by Wafik El-Deiry from 1995 to 1999. On his return to India, he joined the Indian Institute of Science (IISc) as a member of faculty at the division of biological sciences, subsequently became an associate professor at the Department of Microbiology and Cell Biology [3] and continues his association with IISc, serving as a professor. [4] [5] He also heads the research group, popularly known as Prof. Kumar Somasundaram's Lab. [6]

Somasundaram resides in IISc housing colony in Bengaluru, Karnataka. [7]

Legacy

Glioblastoma - MR coronal with contrast Glioblastoma - MR coronal with contrast.jpg
Glioblastoma - MR coronal with contrast

Somasundaram's work is centered around the studies of oncoviruses, tumor suppressor genes, gliomas and microRNAs and he has done advanced research on glioblastoma, an aggressive form of cancer affecting the brain. [8] [9] The group led by him is engaged in work concerning the determination of the role of cellular tumor antigen p53 in glioma, regulating the protein, p73 in cervical cancer patients, using Adenovirus early region 1A, a tumor suppressor gene, the analytical study of BRCA1 gene in breast cancer and the analysis and regulation of SV2A, a synaptic vesicle protein. [3] He demonstrated that glioblastoma spreads rapidly by producing macrophage colony-stimulating factor (MCSF) in large quantities which in turn stimulate the growth of blood vessels in the tumor. [10] He proposed that the MCSF interacted with the anti-tumor microglial cells of the human body and induced them to produce Insulin-like growth factor-binding protein 1 (IGFBP1), thereby impairing the capacity of microglial cells to fight the tumor cells, a process he called befriending. The discovery of this new molecule, IGFBP1 and its role in glioma angiogenesis, led to a collaborative investigation which involved four research institutions namely National Institute of Mental Health and Neuro Sciences, Sri Sathya Sai Institute of Higher Medical Sciences and Institute for Functional Genomics (INSERM) of the University of Montpellier, apart from the IISc. [11] The research team led by Somasundaram and Phillipe Marin of INSERM validated the earlier findings and proposed a new therapeutic protocol for glioblastoma which targeted IGFBP1, rather than Vascular endothelial growth factor (VEGF) which earlier treatment methods attacked. [12] The researchers, later, released their findings through a paper, Glioblastoma-derived Macrophage Colony Stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-Binding Protein 1 (IGFBP1) to Promote Angiogenesis, published in the Journal of Biological Chemistry. [13] Work is in progress at his laboratory for developing biomarkers (twenty genes of which is named gene X, have already been discovered) [14] for which detailed study is being conducted on microRNA, DNA methylation, modifications of chromatin and gene fusions. [4] [15] His studies have been documented by way of a number of articles [16] [17] [note 1] and ResearchGate, an online repository of scientific articles has listed 178 of them. [18] He has also conducted workshops [19] [20] [21] including the Workshop on Next Generation Sequencing organized by the Council of Scientific and Industrial Research in November 2013 [22] and has delivered invited or plenary speeches at various conferences and seminars [23] and the 5th annual meeting of the Proteomics Society, India held in September 2013 was one among them. [24]

Somasundaram is credited with the establishment of the first laboratory for molecular oncology at the IISc and his contributions are also reported in the establishment of a facility for genomics at the institute. [2] He has undertaken many research programs in cancer biology which included the IISC initiative on Cancer Biology and Therapeutics. He serves as the principal investigator of the Genomics Programme of the IISc in collaboration with the New Millennium Indian Technology Leadership Initiative (NMITLI) of the Council of Scientific and Industrial Research (CSIR) and is the co-convener of the DBT - IISc Partnership Program for Advanced Research in Biological Sciences and Bio Engineering. [25] He is a member of the DBT Neurobiology Task force of the Department of Biotechnology, [26] sits in the editorial board of the Cancer Biology and Therapy  [ de ] journal published by Taylor & Francis [27] and is a former member of the senate of the Indian Institute of Science. [28]

Awards and honors

Somasundaram received the International Senior Research Fellowship of the Wellcome Trust in 2004. [2] The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards in 2006. [29] The Indian Academy of Sciences elected him as a fellow in 2007 [30] and he received the elected fellowship of the National Academy of Sciences, India, the same year. [31] The other major Indian science academy, the Indian National Science Academy elected him to fellowship in 2009. [32]

Selected bibliography

See also

Notes

  1. ↑ Please see Selected bibliography section

Related Research Articles

<span class="mw-page-title-main">Brain tumor</span> Neoplasm in the brain

A brain tumor occurs when abnormal cells form within the brain. There are two main types of tumors: malignant (cancerous) tumors and benign (non-cancerous) tumors. These can be further classified as primary tumors, which start within the brain, and secondary tumors, which most commonly have spread from tumors located outside the brain, known as brain metastasis tumors. All types of brain tumors may produce symptoms that vary depending on the size of the tumor and the part of the brain that is involved. Where symptoms exist, they may include headaches, seizures, problems with vision, vomiting and mental changes. Other symptoms may include difficulty walking, speaking, with sensations, or unconsciousness.

<span class="mw-page-title-main">Glioma</span> Tumour of the glial cells of the brain or spine

A glioma is a type of tumor that starts in the glial cells of the brain or the spine. Gliomas comprise about 30 percent of all brain tumors and central nervous system tumours, and 80 percent of all malignant brain tumours.

<span class="mw-page-title-main">Oligodendroglioma</span> Medical condition

Oligodendrogliomas are a type of glioma that are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell. They occur primarily in adults but are also found in children.

<span class="mw-page-title-main">Glioblastoma</span> Aggressive type of brain cancer

Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and has a very poor prognosis for survival. Initial signs and symptoms of glioblastoma are nonspecific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. Symptoms often worsen rapidly and may progress to unconsciousness.

<span class="mw-page-title-main">EMP3</span> Protein-coding gene in the species Homo sapiens

Epithelial membrane protein 3 (EMP3) is a trans-membrane signaling molecule that is encoded by the myelin-related gene EMP3. EMP3 is a member of the peripheral myelin protein gene family 22-kDa (PMP22), which is mainly responsible for the formation of the sheath of compact myelin. Although the detailed functions and mechanisms of EMP3 still remain unclear, it is suggested that EMP3 is possibly epigenetically linked to certain carcinomas.

<span class="mw-page-title-main">Gliosarcoma</span> Medical condition

Gliosarcoma is a rare type of glioma, a cancer of the brain that comes from glial, or supportive, brain cells, as opposed to the neural brain cells. Gliosarcoma is a malignant cancer, and is defined as a glioblastoma consisting of gliomatous and sarcomatous components. Primary gliosarcoma (PGS) is classified as a grade IV tumor and a subtype of glioblastoma multiforme in the 2007 World Health Organization classification system (GBM). Because of a lack of specific and clear diagnostic criteria, the word "gliosarcoma" was frequently used to refer to glial tumours with mesenchymal properties, such as the ability to make collagen and reticulin.

<span class="mw-page-title-main">GLIPR1</span> Protein-coding gene in humans

Glioma pathogenesis-related protein 1 is a protein that in humans is encoded by the GLIPR1 gene.

<span class="mw-page-title-main">M. R. S. Rao</span> Indian scientist (1948–2023)

Manchanahalli Rangaswamy Satyanarayana Rao was an Indian scientist. He was awarded the fourth-highest civilian award, the Padma Shri, for Science and Engineering in 2010. From 2003 to 2013 he was president of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in Bangalore, India.

<span class="mw-page-title-main">Temozolomide</span> Cancer medication

Temozolomide, sold under the brand name Temodar among others, is an anticancer medication used to treat brain tumors such as glioblastoma and anaplastic astrocytoma. It is taken by mouth or via intravenous infusion.

Usha Vijayraghavan is an Indian molecular biologist. She is on the faculty of the Department of Microbiology and Cell Biology, at the Indian Institute of Science. Her major research interests are Molecular Genetics, Plant Development.

Kalappa Muniyappa is an Indian molecular biologist and geneticist, known for his researches on the chromatization of DNA and gene targeting. He is a professor and chairman of the department of biochemistry of the Indian Institute of Science and an elected fellow of the Indian National Science Academy, Indian Academy of Sciences and the National Academy of Sciences, India. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 1995, for his contributions to biological sciences.

<span class="mw-page-title-main">Rajesh Sudhir Gokhale</span> Indian chemical biologist (born 1967)

Rajesh Sudhir Gokhale is currently the Secretary for Department of Biotechnology (DBT) and Department of Science & Technology (DST), Government of India. He joined National Institute of immunology after conducting his postdoctoral training at Stanford University, He was the director of Institute of Genomics and Integrative Biology from 2009 to 2016. Gokhale is known for his studies on the metabolic diversity of pathogens. He is credited with the discovery of a family of Long-chain Fatty acyl-AMP ligases (FAAL) and his studies assisted in the elucidation of biochemical crosstalk between fatty acid synthases and polyketide synthases in Mycobacterium tuberculosis. He holds US and Indian patents for his invention of Method to Modulate Pigmentation Process in the Melanocytes of Skin. An alumnus of the Indian Institute of Science, he is an elected fellow of the Indian Academy of Sciences (2007) and the Indian National Science Academy (2014). The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2006, for his contributions to biological sciences. He received the National Bioscience Award for Career Development of the Department of Biotechnology in 2009.

<span class="mw-page-title-main">Bradley Bernstein</span> Biologist

Bradley E. Bernstein is a biologist and Professor of Cell Biology at Harvard Medical School. He is Chair of the Department of Cancer Biology at the Dana–Farber Cancer Institute and the Director of the Broad Institute's Gene Regulation Observatory. He is known for contributions to the fields of epigenetics and cancer biology.

Saumitra Das is an Indian microbiologist and a professor at the Department of Microbiology and Cell Biology of the Indian Institute of Science. Known for his studies in the fields of molecular virology and molecular biology, Das is an elected fellow of all the three major Indian science academies namely, the Indian Academy of Sciences, the National Academy of Sciences, India and the Indian National Science Academy. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2005.

Nihar Ranjan Jana is an Indian neuroscientist and professor at the IIT Kharagpur, known for his studies on E3 ubiquitin ligases, protein homeostasis and neurodegenerative disorders. Jana is an elected fellow of the National Academy of Sciences, India. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, in 2008 and TATA Innovation Fellowship in 2014 for his contributions to Neurodegenerative diseases.

Ashok M. Raichur is an Indian materials scientist, nanotechnologist and a professor at the Department of Materials Engineering of the Indian Institute of Science, Bangalore. Known for his studies on the use of nanotechnology for biomedical and environmental applications, Raichur is a former Alexander von Humboldt Fellow and a life member of the National Academy of Sciences, India. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2009.

Sagar Sengupta is an Indian immunologist, cancer biologist and a scientist at the National Institute of Immunology, India. Known for his studies on tumor suppressor gene and oncogenes, Sengupta is an elected fellow of all the three major Indian science academies namely the National Academy of Sciences, India, the Indian National Science Academy and the Indian Academy of Sciences. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2011.

Patrick D'Silva is an Indian cell biologist, biochemist, and an associate professor at the Molecular Chaperone Lab of the Indian Institute of Science. He is known for his medical discoveries related to neurodegenerative diseases and cancer biology. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2014.

Ganesh Nagaraju is an Indian biochemist, geneticist, cancer biologist and a full professor at the Department of Biochemistry of the Indian Institute of Science. He has been studying DNA damage responses in mammalian cells, and mechanisms underlying chromosome instability genetic diseases and cancer. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, for his contributions to biosciences, in 2015. In 2018, Nagaraju received the Shanti Swarup Bhatnagar Prize for Science and Technology in Biological Sciences from CSIR. This award is given in recognition of outstanding contributions to Science and Technology, and is considered one of the highest awards for science in India.

Amit Singh is an Indian microbiologist and an associate professor at the department of microbiology and cell biology of the Indian Institute of Science. A Wellcome-DBT Senior Fellow, Singh is known for his studies on the pathogenesis of Mycobacterium tuberculosis. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development for 2017/18. He was awarded with the prestigious CSIR- Shanti Swarup Bhatnagar award on 2021 for his phenomenal contributions in bio-scientific research. He received the 2021 Shanti Swarup Bhatnagar Prize for Science and Technology in Biological Science.

References

  1. ↑ "Fellow profile". Indian Academy of Sciences. 21 December 2017. Retrieved 21 December 2017.
  2. 1 2 3 "Indian fellow - K. Somasundaram". Indian National Science Academy. 21 December 2017. Archived from the original on 23 December 2017. Retrieved 21 December 2017.
  3. 1 2 "Kumaravel Somasundaram, Ph.D. profile in India Cancer Research Database". www.incredb.org. 23 December 2017. Retrieved 23 December 2017.
  4. 1 2 "K. Somasundaram - Division of Biological Sciences, Indian Institute of Science". bio.iisc.ac.in. 23 December 2017. Archived from the original on 31 December 2018. Retrieved 23 December 2017.
  5. ↑ "Department of Microbiology and Cell Biology Profile". 2012.
  6. ↑ "Prof. Kumar Somasundaram's Labe". mcbl.iisc.ac.in. 23 December 2017. Archived from the original on 14 February 2020. Retrieved 23 December 2017.
  7. ↑ "NASI fellows". National Academy of Sciences, India. 21 December 2017. Archived from the original on 16 March 2016. Retrieved 21 December 2017.
  8. ↑ "Scientists discover gene responsible for aggressiveness of brain cancer". 27 June 2016. Retrieved 23 December 2017.
  9. ↑ "Research summary". Indian Institute of Science. 23 December 2017. Archived from the original on 18 February 2020. Retrieved 23 December 2017.
  10. ↑ "IISc finds way to bust brain cancer". Bangalore Mirror. 1 September 2015. Retrieved 23 December 2017.
  11. ↑ Staff Reporter (28 June 2016). "IISc scientists demystify lethal form of brain cancer". The Hindu. ISSN   0971-751X . Retrieved 23 December 2017.
  12. ↑ "IISc scientists identify potential new drug target for brain cancer". 31 August 2015. Retrieved 23 December 2017.
  13. ↑ Nijaguna, Mamatha Bangalore; Patil, Vikas; Urbach, Serge; Shwetha, Shivayogi D.; Sravani, Kotha; Hegde, Alangar S.; Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan; Marin, Philippe (18 September 2015). "Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis". Journal of Biological Chemistry. 290 (38): 23401–23415. doi: 10.1074/jbc.m115.664037 . ISSN   0021-9258. PMC   4645610 . PMID   26245897.
  14. ↑ Johnson T.A. (2005). "IISc scientists find key brain cancer gene". Archived from the original on 23 December 2017. Retrieved 23 December 2017.{{cite news}}: CS1 maint: unfit URL (link)
  15. ↑ "New molecular tests for brain tumor". Nature India. 26 April 2011. doi:10.1038/nindia.2011.59.
  16. ↑ "On Google Scholar". Google Scholar. 23 November 2017. Retrieved 23 November 2017.
  17. ↑ "Browse by Fellow". Indian Academy of Sciences. 23 December 2017. Retrieved 23 December 2017.
  18. ↑ "On ResearchGate". 21 December 2017. Retrieved 21 December 2017.
  19. ↑ "B4 Genomics Workshop Schedule". Lakshmi Mittal South Asia Institute. 23 December 2017. Retrieved 23 December 2017.
  20. ↑ "Ganga Symposium" (PDF). Ganga Hospital. 2016. Archived from the original (PDF) on 23 December 2017. Retrieved 23 December 2017.
  21. ↑ "Workshop on Next Generation Sequencing". www.ccmb.res.in. 2013. Retrieved 23 December 2017.
  22. ↑ "Regulation Of VEGF Gene Expression By PDGF, p73 And Butyric Acid: Role In Tumor Angiogenesis". JNCASR. 23 December 2017. Retrieved 23 December 2017.
  23. ↑ "5th Annual Meeting of the Proteomics Society-India". www.proteomicsindia.in. 2013. Archived from the original on 21 February 2015. Retrieved 23 December 2017.
  24. ↑ "DBT chips in Rs. 6 cr to NIMHANS & IISc for research in brain cancer in adults". Auro Health Care. 12 May 2014. Retrieved 23 December 2017.
  25. ↑ "Database of Experts - DBT Neurobiology Task force". dbt-neuro.ncbs.res.in. 23 December 2017. Archived from the original on 23 December 2017. Retrieved 23 December 2017.
  26. ↑ "Cancer Biology & Therapy". www.tandfonline.com. Retrieved 23 December 2017.
  27. ↑ "Indian Institute of Science - Information per RTI". www.iisc.ernet.in. 2005. Archived from the original on 6 July 2017. Retrieved 23 December 2017.
  28. ↑ "Awardees of National Bioscience Awards for Career Development" (PDF). Department of Biotechnology. 2016. Archived from the original (PDF) on 4 March 2018. Retrieved 20 November 2017.
  29. ↑ "Fellowship - Indian Academy of Sciences". www.ias.ac.in. 21 December 2017. Retrieved 21 December 2017.
  30. ↑ "NASI Year Book 2015" (PDF). National Academy of Sciences, India. 17 December 2017. Archived from the original (PDF) on 6 August 2015. Retrieved 17 December 2017.
  31. ↑ "INSA Year Book 2016" (PDF). Indian National Science Academy. 17 December 2017. Archived from the original (PDF) on 4 November 2016. Retrieved 17 December 2017.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.